SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-100946
Filing Date
2008-05-02
Accepted
2008-05-02 17:29:46
Documents
9
Period of Report
2008-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 33578
2 ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION dex31.htm EX-3.1 105908
3 INDENTURE, DATED APRIL 30, 2008 BETWEEN CELL THERAPEUTICS, INC. AND U.S. BANK dex41.htm EX-4.1 437781
4 FORM OF A WARRANT dex42.htm EX-4.2 60594
5 FORM OF B UNIT WARRANT dex43.htm EX-4.3 54259
6 FORM OF SERIES E 13.5% CONVERTIBLE EXCHANGEABLE PREFERRED STOCK CERTIFICATE dex44.htm EX-4.4 9906
7 OPINION OF HELLER EHRMAN LLP dex51.htm EX-5.1 10420
8 FORM OF PURCHASE AGREEMENT, DATED APRIL 29, 2008 dex101.htm EX-10.1 139774
9 T-1 STATEMENT OF ELIGIBILITY OF U.S. BANK NATIONAL ASSOCIATION dex251.htm EX-25.1 34981
  Complete submission text file 0001193125-08-100946.txt   889014
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 08800203
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1